{"id":"W2488116285","doi":"10.1158/1538-7445.am2016-ct074","title":"Abstract CT074: Phase I/II study of VAL-083 in patients with recurrent glioblastoma","year":2016,"lang":"en","type":"article","venue":"Cancer Research","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Delmar (Canada)","funders":"","keywords":"Temozolomide; Medicine; Bevacizumab; Phases of clinical research; Oncology; Glioma; Internal medicine; Clinical trial; Cancer; Radiation therapy; Glioblastoma; Methyltransferase; Cancer research; Chemotherapy; Biology; DNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001435153,0.001910201,0.002377934,0.0006575512,0.0004794846,0.0008232261,0.001093639,0.001083923,0.003986342],"category_scores_gemma":[0.0007081686,0.0006852118,0.001248475,0.0005787408,0.0009827693,0.0006016266,0.0004027948,0.002920287,0.00131271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001232099,"about_ca_system_score_gemma":0.002484638,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002903838,"about_ca_topic_score_gemma":0.005764448,"domain_scores_codex":[0.9995114,0.00023348,0.00003022982,0.00007621376,0.00004517997,0.0001034869],"domain_scores_gemma":[0.9994361,0.00004958043,0.00007808484,0.00005261898,0.00005971622,0.0003239853],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6704011,0.1190198,0.01377673,0.001105389,0.00182353,0.0005213353,0.0004544213,0.003125497,0.08350147,0.0003228958,0.008634462,0.09731336],"study_design_scores_gemma":[0.3142068,0.6607053,0.0155782,0.00004134761,0.0005229345,0.0003243391,0.0000837026,0.0009627196,0.004640249,0.0001581103,0.002735463,0.00004098556],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929087,0.001289735,0.0003141692,0.0003560353,0.00009418419,0.002367392,0.001339981,0.0001107384,0.001219011],"genre_scores_gemma":[0.9844328,0.001546872,0.001671467,0.0009796638,0.0001539746,0.00344779,0.004134159,0.00005122193,0.00358215],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003986342,"threshold_uncertainty_score":0.01333559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06491319622575849,"score_gpt":0.4267035912718839,"score_spread":0.3617903950461254,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}